The phrase "also identified a low" is not complete and lacks context, but it is grammatically correct and can be used in written English.
You can use it when discussing findings or observations in research or analysis, particularly when referring to a low measurement or value that has been recognized.
Example: "The study also identified a low correlation between the two variables, suggesting that they may not be related."
Alternatives: "also noted a low" or "also found a low".
We also identified a low but significant TDR mutation rate among ART-naive patients.
We also identified a low level of transmitted drug resistance in this population.
A separate mutational analysis also identified a low rate of MEK1 mutations in CRC samples (2.2%), the MEK1 mutation (D67N) having been previously characterized in ovarian cancer cells (discussed in the following section) [ 77].
We also identified a low density lipoprotein receptor A (LDLa) domain and a von Willebrand Factor type A (vWFA) domain in BbZP2, 3, 4 and 5, but none in BbZP1.
The authors also identify a low number of new genes without homologues in data base (ORFans) in Rickettsia.
However, a recent study has demonstrated that HIV-related stigma is a prominent barrier to testing. 10 Studies also identify a low perceived risk as a problematic barrier to HIV testing.
Cross-species analyses also identified a new 'claudin-low' tumor subtype [ 8].
We also identified a group of controls who had low CD8+ T cell activation and high absolute CD4+ T cell counts at the time specimens tested were obtained, defined as: Percentage of circulating CD8+ T co-expressing CD38 and HLA-DR was <10% Absolute CD4+ T cell counts were consistently >500 cells/µL.
Our four-gene analysis also identified a larger assemblage of orders with low BS support including fabids, malvids and Crossosomatales, which constitutes the core part of rosids.
Because the two characteristics studied, prenatal care and socioeconomic status are generally highly correlated with the patient's health status, we also identify a subsample of low-risk women.
Although these signatures were built using a different microarray platform and had only a small gene overlap, a feature common to both signatures is that they correctly identified the high-risk patients while also identifying a higher number of low-risk patients not needing treatment compared to the clinical guidelines.
